Yoneda K, Ota A, Kawashima Y
Central Research Laboratory, Santen Pharmaceutical Co., Ltd., Osaka, Japan.
Chem Pharm Bull (Tokyo). 1993 May;41(5):876-81. doi: 10.1248/cpb.41.876.
A series of N-(mercaptoalkyl)thiazolidine-2-thiones and their derivatives were synthesized and evaluated for hepatoprotective activities against Propionibacterium acnes-lipopolysaccharide (P. acnes-LPS)-induced liver injury in mice and in vitro lipid peroxide (LPO) formation in rat liver microsomes. Reaction of N-(p-methoxybenzylthioalkyl)cysteine methyl ester (11) with 1,1'-thiocarbonyldiimidazole followed by deprotection gave the corresponding thiazolidine-2-thione derivatives. Among the compounds synthesized, 1a and 2a showed the most potent hepatoprotective activities against P. acnes-LPS-induced liver injury. Compounds 1a-f and 4 inhibited LPO formation in vitro. Compounds 1a and 2a were chosen for further pharmacological evaluations.
合成了一系列N-(巯基烷基)噻唑烷-2-硫酮及其衍生物,并对其在小鼠中针对痤疮丙酸杆菌脂多糖(P. acnes-LPS)诱导的肝损伤以及在大鼠肝微粒体中体外脂质过氧化物(LPO)形成的保肝活性进行了评估。N-(对甲氧基苄硫基烷基)半胱氨酸甲酯(11)与1,1'-硫代羰基二咪唑反应,随后脱保护得到相应的噻唑烷-2-硫酮衍生物。在合成的化合物中,1a和2a对P. acnes-LPS诱导的肝损伤表现出最有效的保肝活性。化合物1a-f和4在体外抑制LPO形成。选择化合物1a和2a进行进一步的药理学评估。